Insider Trading & Ownership - Cline Darren S

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cline Darren S
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-08
Purchase
2021-12-09
4:18 pm
Pyxis Oncology Inc.PYXSCline Darren S
Director
10,000$9.3885$93,88510,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-13
Option Award
2024-06-17
8:15 pm
N/A
2034-06-13
PLIANT THERAPEUTICS INC.PLRXCline Darren S
Director
26,764$026,764
(Direct)
View
2024-03-26
Option Award
2024-03-28
4:33 pm
N/A
N/A
Pyxis Oncology Inc.PYXSCline Darren S
Director
35,219$0251,405
(Direct)
View
2023-06-16
Option Award
2023-06-20
6:41 pm
N/A
2033-06-15
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
13,222$013,222
(Direct)
View
2023-06-07
Option Award
2023-06-08
5:09 pm
N/A
2033-06-07
PLIANT THERAPEUTICS INC.PLRXCline Darren S
Director
14,000$014,000
(Direct)
View
2023-04-12
Option Award
2023-04-14
4:58 pm
N/A
2033-04-11
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
20,013$020,013
(Direct)
View

Ownership
2023-04-13
6:10 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director
0$00
(Direct)
View
2023-03-24
Option Award
2023-03-28
4:41 pm
N/A
N/A
Pyxis Oncology Inc.PYXSCline Darren S
Director
139,355$0216,186
(Direct)
View
2023-03-06
Option Award
2023-03-08
4:36 pm
N/A
2033-03-06
PLIANT THERAPEUTICS INC.PLRXCline Darren S
Director
22,000$022,000
(Direct)
View
2022-03-31
Option Award
2022-04-04
4:15 pm
N/A
N/A
Pyxis Oncology Inc.PYXSCline Darren S
Director
66,831$076,831
(Direct)
View
2021-10-07
Option Award
2021-10-12
7:47 pm
N/A
2031-10-07
Pyxis Oncology Inc.PYXSCline Darren S
Director
42,191$042,191
(Direct)
View

Ownership
2021-10-07
9:10 pm
N/A
2031-08-18
Pyxis Oncology Inc.PYXSCline Darren S
Director
0$015,725
(Direct)
View
2021-05-05
Disposition
2021-05-07
4:21 pm
N/A
2029-05-28
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
585,276$00
(Direct)
View
2021-03-02
Option Award
2021-03-04
9:05 pm
N/A
N/A
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
121,920$0121,920
(Direct)
View
2021-02-22
Option Award
2021-02-24
6:53 pm
N/A
N/A
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
121,920$0121,920
(Direct)
View
2020-06-10
Equity Swap
2020-06-10
11:15 am
N/A
N/A
STEMLINE THERAPEUTICS INCSTMLCline Darren S
Director
35,468$00
(Direct)
View
2020-06-04
Option Award
2020-06-08
8:00 pm
N/A
N/A
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
283,500$0283,500
(Direct)
View
2020-05-28
Exercise
2020-05-29
8:00 pm
2020-05-28
2020-05-28
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
7,356$05,556
(Direct)
View
2020-05-28
Tax Withholding
2020-05-29
8:00 pm
N/A
N/A
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
1,800$10.545,556
(Direct)
View
2020-05-28
Exercise
2020-05-29
8:00 pm
N/A
N/A
GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer
7,356$0.00125,556
(Direct)
View